Oct 17, 2022

Cordis Announces Acquisition of MedAlliance

Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology

Read more

Jul 11, 2022

Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe

Multi-center study to evaluate safety and efficacy of S.M.A.R.T. RADIANZ^™ Vascular Stent System via Radial Access

Read more

Jul 8, 2022

Cordis Names Bryan Loo President Of The Asia-Pacific Region

Bryan Loo will head a leadership team responsible for the fast-growing APAC region for Cordis.

Read more

Jun 20, 2022

Cordis Announces Successful First-in-Human Use of the Radianz Radial Peripheral System™

Read more

May 26, 2022

Tribute to Cardiology Pioneer Dr. José Eduardo Sousa

Cordis Pays Tribute to Cardiology Pioneer Dr. José Eduardo Sousa

Read more

Apr 18, 2022

Cordis Makes Strategic Investment in E2

Cordis Makes Strategic Investment in E2, a developer of Next-Generation Thrombectomy Devices Move signals new chapter of innovation for Cordis

Read more

Jan 5, 2022

Cordis names Christopher Scully to CFO Post

Cordis, a global interventional cardiovascular technology company, today announced that Christopher Scully has joined the organization as Chief Finan...

Read more

Dec 8, 2021

Cordis Names Muscari President Of The Americas

Matthew Muscari takes the helm of global marketing and American sales as Cordis pursues path of transformation and growth

Read more

Mar 12, 2021

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion...

Read more